| 2019 |
ELFN2 is a postsynaptic adhesion molecule that selectively binds group III metabotropic glutamate receptors (mGluR4, mGluR6, mGluR7, mGluR8) in trans across the synapse, directly alters G protein coupling kinetics and efficacy of group III mGluRs, and its loss results in selective downregulation of group III mGluRs and dysregulated glutamatergic synaptic transmission. Elfn2 KO mice display seizure susceptibility, hyperactivity, and anxiety/compulsivity rescued by pharmacological augmentation of group III mGluRs. |
Transcellular GPCR signaling platform, Elfn2 knockout mice, electrophysiology, behavioral assays, pharmacological rescue |
Molecular psychiatry |
High |
31485013
|
| 2020 |
ELFN2 is selectively expressed in cone photoreceptors (not rods) and transsynaptically recruits mGluR6 in ON-bipolar cells to enable cone synaptic transmission. ELFN2 functions in synergy with ELFN1 during development to specify selective wiring and transmission of cone signals to ON-type bipolar cells. |
Unbiased proteomics in cone-dominant species, conditional knockout mice, immunolocalization, electrophysiology (ERG), and genetic interaction (ELFN1/ELFN2 double mutants) |
Proceedings of the National Academy of Sciences of the United States of America |
High |
32879010
|
| 2018 |
In GBM cells, ELFN2 promotes autophagy by interacting with Aurora kinase A (AurkA) and eIF2α and inhibiting AurkA activation. ELFN2 expression is epigenetically regulated by promoter hypomethylation, miR-101 downregulation, and the lncRNA LINC00470 (which adsorbs miR-101 and decreases H3K27me3 occupancy at the ELFN2 promoter). |
Co-immunoprecipitation, overexpression/knockdown in GBM cell lines, autophagy assays, methylation analysis, chromatin immunoprecipitation |
Molecular therapy : the journal of the American Society of Gene Therapy |
Medium |
30037656
|
| 2019 |
LRRC62 (ELFN2 alias) functions as an adaptor protein that recruits the deubiquitinase CYLD to TAK1, thereby promoting K63-linked deubiquitination and inactivation of TAK1, resulting in negative regulation of TLR-induced NF-κB and MAPK signaling and reduced pro-inflammatory cytokine production. |
Co-immunoprecipitation, overexpression and knockdown in cell lines, cytokine production assays, ubiquitination assays |
Experimental cell research |
Medium |
31301291
|
| 2024 |
Complex N-glycosylation of mGluR6 is required for its trans-synaptic interaction with ELFN2 (and ELFN1). Pull-down experiments with ELFN2 extracellular domains showed interaction exclusively with complex-glycosylated mGluR6. Mutation at N445 of mGluR6 severely impaired ELFN2 binding. N-glycosylation at N445 is sufficient but not necessary for dendritic tip localization of mGluR6. |
Glycosidase treatment (PNGase F, Endo H), pulldown assays with ELFN2 extracellular domain, site-directed mutagenesis of N-glycosylation sites, surface expression and localization assays in heterologous cells and rod bipolar cells |
The Journal of biological chemistry |
High |
38428819
|
| 2024 |
ELFN2 forms homodimers prior to membrane trafficking, utilizing the extracellular leucine-rich repeat (LRR) domain for dimerization. ELFN2 also participates in heterodimerization with ELFN1. The intracellular domain controls membrane targeting and postsynaptic localization, with a ~30 amino acid juxtamembranous region required for membrane-targeting, and a single membrane-targeting motif in one protomer is sufficient for trafficking of the homodimer. |
Domain deletion/mutagenesis, co-immunoprecipitation for dimerization, subcellular fractionation, live-cell imaging, postsynaptic localization assays |
The Journal of biological chemistry |
Medium |
39675706
|
| 2026 |
ELFN2 interacts directly with the catalytic subunit alpha of protein phosphatase-1 (PP1A) and inhibits PP1A-mediated dephosphorylation of YAP at Ser127, thereby promoting YAP nuclear export and functional inactivation, suppressing lymph node metastasis in gastric cancer. Pharmacological inhibition of PP1A abrogated ELFN2-induced YAP inactivation. |
Co-immunoprecipitation, phosphorylation assays, PP1A inhibitor pharmacology, in vivo metastasis models (lymph node and peritoneal carcinomatosis) |
Experimental cell research |
Medium |
41967793
|
| 2021 |
ELFN2 (and ELFN1) can interact in trans with all group III mGluRs (mGluR4, mGluR6, mGluR7, mGluR8) and alter mGluR-mediated signaling through these trans-interactions. Postsynaptic ELFN2 in the brain mediates regulation of excitatory input through recruitment of presynaptic group III mGluRs. |
Review synthesizing results from multiple studies including transcellular signaling assays and KO models (mechanistic synthesis/review article citing primary data) |
Frontiers in neural circuits |
Medium |
33790745
|
| 2026 |
ELFN2 is mislocalized at cone pedicles when mGluR6 is ablated prior to synaptogenesis during human retinal development (in iPSC-derived organoids), indicating that mGluR6 is required for proper ELFN2 localization during circuit assembly. |
CRISPR-based genetic ablation in human iPSC-derived retinal organoids, immunofluorescence localization |
bioRxiv : the preprint server for biologypreprint |
Low |
42094404
|